Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05958199
Title Treatment With NPX267 for Subjects With Solid Tumors Known to Express HHLA-2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NextPoint Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.